Keros Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $15M | 336k | 45.70 |
| 2024-03-31 | $19M | 289k | 66.20 |
| 2023-12-31 | $37M | 925k | 39.76 |
| 2023-09-30 | $14M | 449k | 31.88 |
| 2023-06-30 | $2.0M | 50k | 40.18 |
| 2022-12-31 | $6.9M | 143k | 48.00 |
| 2022-06-30 | $3.9M | 120k | 32.26 |
| 2022-03-31 | $2.8M | 52k | 54.39 |
| 2021-06-30 | $0 | 23k | 0.00 |
| 2020-12-31 | $5.3M | 76k | 70.58 |
| 2020-09-30 | $24k | 627 | 38.28 |
| 2020-06-30 | $81k | 2.2k | 37.62 |